Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors

被引:55
作者
Malumbres, M [1 ]
Ortega, S [1 ]
Barbacid, M [1 ]
机构
[1] Ctr Nacl Invest Oncol Carlos III, Mol Oncol Program, E-28220 Madrid, Spain
关键词
Cip/Kip inhibitors; cyclin; cyclin-dependent kinase; gene targeting; INK4; inhibitors;
D O I
10.1515/BC.2000.105
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Entry into the cell cycle, in particular the G1/S transition, is a tightly regulated process that involves a combination of mitogenic signaling pathways and cell cycle checkpoints. Some of the key regulators of this process are frequently altered in human cancer. Although the proteins that control the G1/S transition have been extensively studied at the biochemical level, little is known regarding their physiological role in vivo. During the last few years, a series of mouse strains carrying gene targeted mutations in key regulators of the G1/S transition have been generated. They include the Rb family of proteins and some of their downstream and upstream regulators. The latter include the regulatory (cyclin) and catalytic (Cdk) subunits of some of the kinases responsible for Rb inactivation as well as all the members of two families of cell cycle inhibitors, the INK4 and the Cip/Kip proteins. In this review, we summarize the most relevant information derived from the characterization of these strains of mice and attempt to integrate it within a functional framework of cell cycle regulation in vivo.
引用
收藏
页码:827 / 838
页数:12
相关论文
共 76 条
[41]   Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis [J].
Philipp, J ;
Vo, K ;
Gurley, KE ;
Seidel, K ;
Kemp, CJ .
ONCOGENE, 1999, 18 (33) :4689-4698
[42]   Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia [J].
Rane, SG ;
Dubus, P ;
Mettus, RV ;
Galbreath, EJ ;
Boden, G ;
Reddy, EP ;
Barbacid, M .
NATURE GENETICS, 1999, 22 (01) :44-52
[43]   Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo [J].
Robles, AI ;
Rodriguez-Puebla, ML ;
Glick, AB ;
Trempus, C ;
Hansen, L ;
Sicinski, P ;
Tennant, RW ;
Weinberg, RA ;
Yuspa, SH ;
Conti, CJ .
GENES & DEVELOPMENT, 1998, 12 (16) :2469-2474
[44]   The INK4 family of cell cycle inhibitors in cancer [J].
Roussel, MF .
ONCOGENE, 1999, 18 (38) :5311-5317
[45]   The p16INK4a/CDKN2A tumor suppressor and its relatives [J].
Ruas, M ;
Peters, G .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1998, 1378 (02) :F115-F177
[46]   Role of the INK4a locus in tumor suppression and cell mortality [J].
Serrano, M ;
Lee, HW ;
Chin, L ;
CordonCardo, C ;
Beach, D ;
DePinho, RA .
CELL, 1996, 85 (01) :27-37
[47]   The INK4A/ARF locus and its two gene products [J].
Sharpless, NE ;
DePinho, RA .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) :22-30
[48]   INHIBITORS OF MAMMALIAN G(1) CYCLIN-DEPENDENT KINASES [J].
SHERR, CJ ;
ROBERTS, JM .
GENES & DEVELOPMENT, 1995, 9 (10) :1149-1163
[49]   The ARF/p53 pathway [J].
Sherr, CJ ;
Weber, JD .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2000, 10 (01) :94-99
[50]   Cancer cell cycles [J].
Sherr, CJ .
SCIENCE, 1996, 274 (5293) :1672-1677